News
(Reuters) -Swiss drugmaker Roche Holding plans to investigate whether an experimental medicine can delay or prevent Alzheimer ...
(Reuters) -Swiss drugmaker Roche Holding plans to test whether an experimental medicine can prevent Alzheimer's disease ...
Acknowledging the limits of disease-modifying drugs like Leqembi and Kisunla, companies like Bristol Myers Squibb, Acadia, ...
These five upcoming data drops could usher in more effective and convenient therapies for Alzheimer’s disease and open up ...
Eli Lilly and Company (NYSE:LLY) is experiencing a strong analyst sentiment amid its expanding role in cutting-edge ...
The market value of the company surpassed the size of Denmark’s entire economy last year and, for a period, Novo Nordisk was ...
5h
Free Malaysia Today on MSNRoche to study if new drug can delay or prevent Alzheimer’s
The trial drug Trontinemab is designed to bypass the blood brain barrier, delivering more treatment directly to the brain.
Global pharmaceutical giants make billions of dollars in Australia but pay a fraction of that in tax. They say the price they ...
Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...
Obesity, it says, isn’t just the outcome of ghee-laced parathas and Netflix binges. It’s a chronic condition shaped by genes, ...
Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...
This article delves into the approved weight loss drugs in India, their costs, and the growing market for such medications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results